Looking for a thorough discussion on the CJC-1295/Ipamorelin combination as a GH secretagogue stack. I'm 44, training consistently, on semaglutide 2.4 mg for weight management, and interested in the potential body composition benefits of optimizing GH levels without going the exogenous HGH route.

My recent IGF-1 came back at 142 ng/mL (reference 87-238 for my age), so I'm not deficient but I'm on the lower side of normal. Sleep quality has been declining and recovery from training sessions isn't what it used to be.

What's the actual evidence for this combination? And is it reasonable to stack with a GLP-1 RA?

This is one of the most popular peptide stacks and for good reason — the pharmacological rationale is sound.

CJC-1295 (with DAC): A synthetic analog of GHRH (growth hormone releasing hormone) with a Drug Affinity Complex that extends its half-life to ~8 days. It increases baseline GH pulsatility. Teichman et al. (2006, PMID: 16352683) showed dose-dependent increases in GH and IGF-1 in healthy subjects — a 2 mg dose produced sustained IGF-1 elevation for up to 28 days.

CJC-1295 (no DAC) aka Mod GRF 1-29: Same GHRH analog but without the DAC extension. Half-life of ~30 minutes. Requires more frequent dosing but produces more physiologic GH pulses rather than sustained elevation.

Ipamorelin: A selective GH secretagogue (ghrelin mimetic) that stimulates GH release via the GHSR (growth hormone secretagogue receptor). Raun et al. (1998, PMID: 9849822) demonstrated it produces GH release without significantly affecting cortisol or prolactin — which sets it apart from older secretagogues like GHRP-6 and hexarelin.

The combination works because GHRH analogs and ghrelin mimetics are synergistic — they stimulate GH release through different mechanisms. GHRH acts at the pituitary somatotrophs, while ghrelin mimetics act at both the hypothalamic and pituitary level. Used together, they produce a greater GH pulse than either alone.

I've been running this stack for about 6 months alongside semaglutide 1.7 mg. Here's my protocol and results:

Protocol:

• Mod GRF 1-29 (CJC-1295 no DAC): 100 mcg
• Ipamorelin: 200 mcg
• Combined in one injection, subcutaneous, administered before bed on an empty stomach (fasted at least 2 hours)
• 5 nights per week (weeknights), off weekends

Results after 6 months:

• IGF-1 went from 155 to 211 ng/mL
• Subjective sleep quality improvement — deeper sleep, more vivid dreams, feeling more rested
• Better recovery from training — DOMS duration decreased noticeably
• Some improvement in skin quality (wife noticed, not just me)
• Body comp: lost an additional 4 lbs while maintaining/slightly increasing lean mass (DEXA confirmed)

The semaglutide and CJC/Ipa seem to complement each other well. Sema handles appetite/caloric intake, while the GH peptides may help partition nutrients toward lean tissue. Theoretically the lipolytic effects of GH and the weight loss effects of GLP-1 RAs could be additive.

That's encouraging. A few questions about your protocol:

administered before bed on an empty stomach

Why bedtime? And how strict is the fasting requirement? With semaglutide I'm often not hungry in the evening anyway, so fasting isn't hard, but I want to understand the rationale.

Two reasons for bedtime dosing:

1. GH physiology: The largest natural GH pulse occurs during deep sleep (SWS, stages 3-4). Administering secretagogues before bed amplifies this natural pulse rather than creating an unphysiologic daytime spike. You're working with your biology, not against it.
2. Fasting state: Elevated blood glucose and insulin suppress GH release. This is well-established — hyperglycemia blunts the GH response to GHRH (see Ho et al., 1988, PMID: 3127426). You want insulin and blood glucose low when the peptides hit. A 2-3 hour fast before dosing is the practical recommendation. Some people are even stricter (no carbs at the last meal before dosing).

An alternative timing is first thing in the morning, fasted, but most people find bedtime more practical and the sleep benefits are a nice bonus.

Also worth noting: semaglutide itself may actually help here. By reducing food intake and improving insulin sensitivity, GLP-1 RAs create a metabolic environment that's more favorable for GH secretion. Your lower fasting insulin and glucose levels may enhance the response to CJC/Ipa compared to someone not on a GLP-1 RA.